192 related articles for article (PubMed ID: 28710469)
1. Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns.
Chen H; Xue L; Wang H; Wang Z; Wu H
Sci Rep; 2017 Jul; 7(1):5470. PubMed ID: 28710469
[TBL] [Abstract][Full Text] [Related]
2. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
[TBL] [Abstract][Full Text] [Related]
3. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.
Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T
Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805
[TBL] [Abstract][Full Text] [Related]
4. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.
Paganini I; Capone GL; Vitte J; Sestini R; Putignano AL; Giovannini M; Papi L
J Neurooncol; 2018 Mar; 137(1):33-38. PubMed ID: 29230670
[TBL] [Abstract][Full Text] [Related]
5. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
6. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
[TBL] [Abstract][Full Text] [Related]
9. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
Koutsimpelas D; Ruerup G; Mann WJ; Brieger J
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):33-7. PubMed ID: 22249120
[TBL] [Abstract][Full Text] [Related]
10. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
12. The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals.
Chen H; Zhang X; Zhang Z; Yang T; Wang Z; Wu H
Mol Cell Biochem; 2014 Jul; 392(1-2):145-52. PubMed ID: 24619252
[TBL] [Abstract][Full Text] [Related]
13. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
Warren C; James LA; Ramsden RT; Wallace A; Baser ME; Varley JM; Evans DG
J Med Genet; 2003 Nov; 40(11):802-6. PubMed ID: 14627667
[TBL] [Abstract][Full Text] [Related]
14. Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants.
Carlson ML; Smadbeck JB; Link MJ; Klee EW; Vasmatzis G; Schimmenti LA
Otol Neurotol; 2018 Oct; 39(9):e860-e871. PubMed ID: 30106846
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China.
Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ
J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976
[TBL] [Abstract][Full Text] [Related]
16. Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma.
Zhang Z; Wang Z; Sun L; Li X; Huang Q; Yang T; Wu H
Genet Med; 2014 Mar; 16(3):264-70. PubMed ID: 24030433
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
18. Sporadic vestibular schwannoma: a molecular testing summary.
Sadler KV; Bowers NL; Hartley C; Smith PT; Tobi S; Wallace AJ; King A; Lloyd SKW; Rutherford S; Pathmanaban ON; Hammerbeck-Ward C; Freeman S; Stapleton E; Taylor A; Shaw A; Halliday D; Smith MJ; Evans DG
J Med Genet; 2021 Apr; 58(4):227-233. PubMed ID: 32576656
[TBL] [Abstract][Full Text] [Related]
19. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
20. Clinical risk factor analysis of bilateral vestibular schwannoma's growth pattern inconsistency in individual NF2 patients.
Li P; Li S; Wang Y; Zhao F; Wang Z; Wang X; Wang B; Yang Z; Liu P
Clin Neurol Neurosurg; 2021 Jan; 200():106365. PubMed ID: 33243701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]